APA (7th ed.) Citation

Novković, S. S., Šelemetjev, S., Krajnović, M., Božović, A., Kožik, B., Zmrzljak, U. P., & Denčić, T. I. (2025). Implication of p16 Promoter Methylation, the BRAFV600E Mutation, and ETS1 Expression Determination on Papillary Thyroid Carcinoma Prognosis and High-Risk Patients’ Selection. MDPI AG.

Chicago Style (17th ed.) Citation

Novković, Stefana Stojanović, Sonja Šelemetjev, Milena Krajnović, Ana Božović, Bojana Kožik, Uršula Prosenc Zmrzljak, and Tijana Išić Denčić. Implication of P16 Promoter Methylation, the BRAFV600E Mutation, and ETS1 Expression Determination on Papillary Thyroid Carcinoma Prognosis and High-Risk Patients’ Selection. MDPI AG, 2025.

MLA (9th ed.) Citation

Novković, Stefana Stojanović, et al. Implication of P16 Promoter Methylation, the BRAFV600E Mutation, and ETS1 Expression Determination on Papillary Thyroid Carcinoma Prognosis and High-Risk Patients’ Selection. MDPI AG, 2025.